Stock Ratios
Making an investment decision in the stock market involves a certain amount of risk, so it's important to thoroughly review a company's stock before making any decisions. Stock float, number of short positions and outstanding shares are among the many factors an investor should take into account.
profit margin TTM
3.26%
operating margin TTM
-8.75%
revenue TTM
101.66 Million
revenue per share TTM
1.86$
valuation ratios | |
|---|---|
| pe ratio | 13.88 |
| peg ratio | -0.17 |
| price to book ratio | 0.62 |
| price to sales ratio | 0.46 |
| enterprise value multiple | -115.88 |
| price fair value | 0.62 |
profitability ratios | |
|---|---|
| gross profit margin | 111.88% |
| operating profit margin | -8.75% |
| pretax profit margin | 4.02% |
| net profit margin | 3.26% |
| return on assets | 2.17% |
| return on equity | 3.36% |
| return on capital employed | -9.14% |
liquidity ratio | |
|---|---|
| current ratio | 2.68 |
| quick ratio | 2.68 |
| cash ratio | 1.55 |
efficiency ratio | |
|---|---|
| days of inventory outstanding | 0.00 |
| operating cycle | 216.41 |
| days of payables outstanding | -208.27 |
| cash conversion cycle | 424.68 |
| receivables turnover | 1.69 |
| payables turnover | -1.75 |
| inventory turnover | 0.00 |
debt and solvency ratios | |
|---|---|
| debt ratio | 0.03 |
| debt equity ratio | 0.07 |
| long term debt to capitalization | 0.00 |
| total debt to capitalization | 0.07 |
| interest coverage | -8.18 |
| cash flow to debt ratio | -3.79 |
cash flow ratios | |
|---|---|
| free cash flow per share | -0.32 |
| cash per share | 1.41 |
| operating cash flow per share | -0.32 |
| free cash flow operating cash flow ratio | 1.00 |
| cash flow coverage ratios | -3.79 |
| short term coverage ratios | 0.00 |
| capital expenditure coverage ratio | 0.00 |
Frequently Asked Questions
When was the last time Spero Therapeutics, Inc. (NASDAQ:SPRO) reported earnings?
Spero Therapeutics, Inc. (SPRO) published its most recent earnings results on 14-11-2024.
What is Spero Therapeutics, Inc.'s current ROE?
An investor's main concern is the profitability ratios of a company so that they are able to understand how it performs financially. Investors are interested in finding out how effectively a business is using their cash to produce earnings, which is why return on equity (ROE) ratio is important. Spero Therapeutics, Inc. (NASDAQ:SPRO)'s trailing twelve months ROE is 3.36%.
What are ROA telling us?
The Return on Assets (ROA) ratio measures how profitable a company is relative to its total assets. Spero Therapeutics, Inc. (SPRO) currently has a ROA of 2.17%. Companies that manage their assets effectively will have greater returns, while those that do so poorly would suffer lower returns.
Where did SPRO's net profit margin stand at?
SPRO reported a profit margin of 3.26% in the last quarter. A company's profit margin, also known as its revenue ratio or gross profit ratio, reflects the amount of revenue that an organization earns compared to its net income. In general, a higher ratio implies greater profit, and vice versa.
What is SPRO's short-term liquidity position?
Apple's current ratio, which measures its ability to pay short-term obligations, was 2.68 in the most recent quarter. The quick ratio stood at 2.68, with a Debt/Eq ratio of 0.07.